कृपया अन्य खोज का प्रयास करें
Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally. It operates through four divisions: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services. The company is involved in the sale of various healthcare, personal care, and homecare products through FMCG retailers and corporate pharmacies; OTC medicinal products through corporate and independent pharmacies; branded and generic prescription products, and specialized instrumentation and surgical products; and hospital products in oral solid dosage formulations, syrups, intravenous, and injectable dosage forms. It offers its products for allergies, antiretroviral, baby care, cardiovascular, cannabidiol, central nervous system, colds and flu, cough, dermatology, digestive well-being, energy, feminine hygiene, food and nutrition supplements, gastroenterology, generics, ophthalmology, pain, personal care, respiratory, vitamins, minerals supplements, and women’s health. The company also provides renal healthcare services. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Basadifeela Letsoalo | 59 | 2016 | Executive Director of Transformation & Human Capital and Executive Director |
Andrew Gideon Hall | 60 | 2008 | CEO & Executive Director |
Dorette Neethling | 48 | 2016 | CFO & Executive Director |
Nompumelelo Thembekile Madisa | 42 | 2017 | Non-Executive Chairperson |
Claudia Estelle Manning | 57 | 2016 | Independent Non-Executive Director |
Sibongile Gumbi | 50 | 2019 | Independent Non-Executive Director |
Lulama Boyce | 44 | 2017 | Non-Executive Director |
Debra Ransby | 50 | 2019 | Independent Non-Executive Director |
Michael Sathekge | - | 2020 | Independent Non-Executive Director |
Busisiwe Abigail Mabuza | 60 | 2022 | Lead Independent Director |
Mark John Steyn | 52 | 2023 | Non-Executive Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है